EQ-5D health utility gains with once-weekly semaglutide 2.4 mg in people with MASH and F2/F3 fibrosis: An analysis of ESSENCE

JHEP Reports · Elsevier

Аннотация

Publication date: November 2026 Source: JHEP Reports, Volume 8, Issue 11 Author(s): Margarida Augusto, Robert Bauer, Simon Clancy, Aslak Sindbjerg Poulsen, Fotis Tefos, Michelle Long

Читать у издателя →

Похожие статьи